MYC and neoplasm: Simultaneous inhibition of CDK7 and CDK12/13 with THZ1 abrogates c-MYC expression and decreases tumor growth in platinum- and PARP inhibitor-resistant patient-derived xenograft (PDX) models of HGSOC (91).